Business
Mesoblast (ASX:MSB) share price surges on new results
The Mesoblast limited (ASX: MSB) share price surged this morning after the biotech company announced positive drug trial results.
Mesoblast shares stormed almost 9% higher in early trading before retreating through the morning. At the time of writing, the Mesoblast share price is up 2.54% at $2.62.
Drug trial success
In today’s release, the company detailed significant results for its phase 3 chronic lower back pain trials.
Mesoblast reported that a single injection of its drug rexlemestrocel-L may provide “safe, durable, and effective” therapy for patients with chronic inflammatory back pain due to degenerative disc disease. Furthermore, the results showed the treatment was long-lasting in combination with hyaluronic acid…
-
General7 hours agoWondering about winter | The Spectator Australia
-
Noosa News14 hours agoMan charged with murder after wife found dead in suspicious house fire near Toowoomba
-
Noosa News16 hours agoOz Lotto’s $70 million jackpot won by Queensland syndicate – but not all of the winners know yet
-
General21 hours agoAussie star Cate Blanchett says she is ‘serious’ about giving up acting